RVL Pharmaceuticals plc Lessee, Operating Lease, Liability, to be Paid, Year Three
RVL Pharmaceuticals plc had Lessee, Operating Lease, Liability, to be Paid, Year Three of $112.00 thousand as of 2021-12-31, per its 10-K filed 2022-03-30.
Discontinued › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree · last filed 2022-03-30
- 2021-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Three $112.00K.
- 2020-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Three $261.00K; Lessee, Operating Lease, Liability, to be Paid, Year Three as first filed $554.00K.
- 2019-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Three $929.00K.
- 2019-09-30: Lessee, Operating Lease, Liability, to be Paid, Year Three $1.92M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year Three | Lessee, Operating Lease, Liability, to be Paid, Year Three as first filed |
|---|---|---|
| 2021-12-31 | $112.00K 10-K · filed 2022-03-30 | |
| 2020-12-31 | $261.00K 8-K · filed 2021-09-08 | $554.00K 10-K · filed 2021-03-30 |
| 2019-12-31 | $929.00K 10-K · filed 2020-03-19 | |
| 2019-09-30 | $1.92M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $2.05M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $1.80M 10-Q · filed 2019-05-09 |